TMO TMO

Thermo Fisher Scientific Stock Price

FREE TMO REPORT

573.63
-3.74 (-0.65%)
Upgrade to Real-Time
Afterhours (Closed)
573.63
Volume 1,110,087
Bid Price
Ask Price
News -
Day High 577.51

Low
475.77

52 Week Range

High
618.355

Day Low 568.19
Company Name Stock Ticker Symbol Market Type
Thermo Fisher Scientific Inc TMO NYSE Common Stock
  Price Change Change Percent Stock Price Last Traded
-3.74 -0.65% 573.63 19:19:05
Open Price Low Price High Price Close Price Prev Close
574.90 568.19 577.51 573.63 577.37
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
29,079 1,110,087 $ 573.37 $ 636,486,642 - 475.77 - 618.355
Last Trade Time Type Quantity Stock Price Currency
19:09:58 1 $ 569.37 USD

Period:

Draw Mode:

Thermo Fisher Scientific Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 224.98B 392.20M 391.64M $ 39.21B $ 6.31B 19.45 32.30
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ 1.04 0.21% 12/14/22 -100.60k 0.40%

more financials information »

Thermo Fisher Scientific News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical TMO Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week583.60609.85566.925588.931,848,980-9.97-1.71%
1 Month552.80609.85522.78572.511,885,83520.833.77%
3 Months493.27609.85483.73553.301,567,70280.3616.29%
6 Months573.01611.06475.77545.681,455,8320.620.11%
1 Year567.24618.355475.77550.291,460,0706.391.13%
3 Years327.36672.34250.21481.971,567,513246.2775.23%
5 Years219.40672.34194.51399.411,482,649354.23161.45%

Thermo Fisher Scientific Description

Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of mid-2022 (revenue figures include some cross-segment revenue): analytical technologies (15% of sales); specialty diagnostic products (10%); life science solutions (30%); and lab products and services, which includes CRO services (51%).